It Tech Packaging, Inc.ITP

IT Tech Packaging, Inc. calls itself “a leading manufacturer and distributor of diversified paper products in North China,” and its tissue-paper lines are indeed spinning up to full capacity. The company’s latest 10-Q, filed for the quarter ended 30 September 2025, shows revenue of $25.6 million, a figure that still leaves the company $1.4 million in the red. Operating income is a polite term for a $992,632 shortfall, while net cash from operations trickled in at just $388,450-enough to buy a small warehouse, but not enough to cover the quarter’s payroll without a second mortgage.

The shiny brochures on the website feature high-resolution photographs of gleaming reels and smiling executives, but the SEC numbers tell a plainer story: inventories rose by $1.5 million in the same three months, swelling the on-hand stack of unsold tissue to $3.9 million. The company was also invited to the China International Paper Technology Exhibition, where it pitched its upgraded kit to potential buyers; the exhibit floor may have been buzzing, yet back in Shanxi the cash register is still a reluctant participant. Management’s commentary cheerfully asserts that tissue-paper sales will keep climbing, but the filings remain mute on when the unit economics will flip from red to black.

ITP’s latest SEC package-an NT 10-Q for the quarter to 30 September 2025-lists total assets of $175.7 million, liabilities of $23.6 million, and shareholders’ equity of $152.0 million. Cash used in operations was a meagre $388,450, while capex on plant and machinery was a trifling $29,977-so small it may as well have been the cost of a single high-end tissue converting line. Diluted EPS came in at minus $0.11 on 13.6 million shares; the share count keeps drifting upward, diluting yesterday’s losses into today’s slightly larger pile of red ink. The company’s tissue capacity is running hot, but the balance sheet is still in the slow lane (source: SEC EDGAR 10-Q, period ending 2025-09-30, https://www.sec.gov/Archives/edgar/data/1358190/000121390025110001/ea0264536-10q_ittech.htm).

For readers who like hard numbers, the tissue business is now the company’s flagship story; the product pages at itpackaging.cn list tissue rolls alongside other paper grades, and recent press notes trumpet “tissue paper production lines are now running at full production capacity to fulfill orders.” That is more statement of intent than proof of margin, however, because the same filings show inventories rising faster than collections. The China International Paper Technology Exhibition invite, complete with photographs of Mr Liu Zhenyong shaking hands in front of a branded backdrop, is glossy proof that the company is courting customers, not that it has cracked the unit economics yet (source: tissue production update, https://www.itpackaging.cn/news_detail-39-53-36.html; exhibition invite, https://www.itpackaging.cn/news_detail-39-53-43.html; product rail, https://www.itpackaging.cn/product-54-0-0.html).

What we do not yet know is when the tissue unit will graduate from capacity utilisation bragging rights to actual profitability. The 10-Q is silent on segment margins, and the most recent 8-K is a governance footnote about shareholder votes, not a cash-flow rescue. The company’s own investor materials speak in aspirational language about “improved revenues and profitability,” but the latest quarter’s net loss is the clearest counter-evidence. Until inventories stop swelling and cash from operations stops resembling pocket money, the story remains one of production theatre rather than profit reality.

The SEC submission index and companyfacts JSON confirm that the latest filed numbers are the ones above, and there is no newer 10-Q or 10-K to contradict them. Absent a follow-up filing that shows a genuine swing to positive operating cash and segment profitability, the tissue story is still waiting for its first real payoff (source: SEC EDGAR filing index for CIK 1358190, https://www.sec.gov/edgar/browse/?CIK=1358190; SEC companyfacts JSON for CIK 0001358190, https://data.sec.gov/api/xbrl/companyfacts/CIK0001358190.json).